Based on its share price, down 75% in the last three years, it's easy to write off Moderna (NASDAQ: MRNA) as a biotech ...

Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat the highly contagious stomach virus.

Shares of Moderna Inc. climbed nearly 1% on Friday, reaching levels last seen on Jan. 10, as retail sentiment turned ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Less than a day into his second term, President Donald Trump ordered a freeze on communications at major public health ...

Health-care companies rose as traders rotated back into the sector amid optimism about blockbuster drugs. Novo Nordisk shares rose by more than 8% for one of their biggest gains in recent years after ...

The RSI can be a tricky indicator. When it's below 30, it suggests an "oversold" condition, which, over the short-term, might suggest a bounce is due. And when it's above the "overbought" threshold of ...

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...

A remarkable collection of 364 gold and silver coins from the 14th and 15th centuries has been unearthed in the ancient village of Huqoq, located near the Sea of Galilee in Israel. Archaeologists ...